These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 23202797)
1. Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes. Chen H; Zhang D; Chao SP; Ren JH; Xu L; Jiang XJ; Wang SM Acta Pharmacol Sin; 2013 Feb; 34(2):221-30. PubMed ID: 23202797 [TBL] [Abstract][Full Text] [Related]
2. Effects of L-type Calcium Channel Antagonists Verapamil and Diltiazem on fKv1.4ΔN Currents in Xenopus oocytes. Chen H; Zhang D; Hua Ren J; Ping Chao S Iran J Pharm Res; 2013; 12(4):855-66. PubMed ID: 24523765 [TBL] [Abstract][Full Text] [Related]
3. Effects of diltiazem and propafenone on the inactivation and recovery kinetics of fKv1.4 channel currents expressed in Xenopus oocytes. Zhang D; Wang SM; Chen H; Jiang XJ; Chao SP Acta Pharmacol Sin; 2011 Apr; 32(4):465-77. PubMed ID: 21468083 [TBL] [Abstract][Full Text] [Related]
4. Effect of amiodarone on Kv1.4 channel C-type inactivation: comparison of its effects with those induced by propafenone and verapamil. Xu L; Huang C; Chen J; Jiang X; Li X; Bett GC; Rasmusson RL; Wang S Pharmazie; 2008 Jun; 63(6):475-9. PubMed ID: 18604993 [TBL] [Abstract][Full Text] [Related]
5. Effect of propafenone on Kv1.4 inactivation. Tian L; Jiang X; Rasmusson R; Wang S J Physiol Biochem; 2006 Dec; 62(4):263-70. PubMed ID: 17615952 [TBL] [Abstract][Full Text] [Related]
6. Effects of ginseng-spikenard heart-nourishing capsule on inactivation of C-type Kv1.4 potassium channel. Wang ZQ; Jiang XJ; Zhang GY; Chen M; Tong CF; Zhang D Pak J Pharm Sci; 2016 Sep; 29(5):1513-1517. PubMed ID: 27731805 [TBL] [Abstract][Full Text] [Related]
7. Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+. Wang Z; Wang S; Li J; Jiang X; Wang N J Korean Med Sci; 2009 Feb; 24(1):84-91. PubMed ID: 19270818 [TBL] [Abstract][Full Text] [Related]
8. State-dependent trapping of flecainide in the cardiac sodium channel. Ramos E; O'leary ME J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045 [TBL] [Abstract][Full Text] [Related]
10. Molecular basis involved in the blocking effect of antidepressant metergoline on C-type inactivation of Kv1.4 channel. Bai HW; Eom S; Yeom HD; Nguyen KVA; Lee J; Sohn SO; Lee JH Neuropharmacology; 2019 Mar; 146():65-73. PubMed ID: 30465811 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cardiac two-pore-domain K+ (K2P) channels by the antiarrhythmic drug vernakalant--comparison with flecainide. Seyler C; Li J; Schweizer PA; Katus HA; Thomas D Eur J Pharmacol; 2014 Feb; 724():51-7. PubMed ID: 24374008 [TBL] [Abstract][Full Text] [Related]
12. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes. Yue L; Feng JL; Wang Z; Nattel S Cardiovasc Res; 2000 Apr; 46(1):151-61. PubMed ID: 10727663 [TBL] [Abstract][Full Text] [Related]
13. Blocking effect of methylflavonolamine on human Na(V)1.5 channels expressed in Xenopus laevis oocytes and on sodium currents in rabbit ventricular myocytes. Fan XR; Ma JH; Zhang PH; Xing JL Acta Pharmacol Sin; 2010 Mar; 31(3):297-306. PubMed ID: 20173760 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic and bradycardic drugs inhibit currents of cloned K+ channels, KV1.2 and KV1.4. Yamagishi T; Ishii K; Taira N Eur J Pharmacol; 1995 Aug; 281(2):151-9. PubMed ID: 7589202 [TBL] [Abstract][Full Text] [Related]
15. C-type inactivation involves a significant decrease in the intracellular aqueous pore volume of Kv1.4 K+ channels expressed in Xenopus oocytes. Jiang X; Bett GC; Li X; Bondarenko VE; Rasmusson RL J Physiol; 2003 Jun; 549(Pt 3):683-95. PubMed ID: 12730347 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the voltage-dependent K An JR; Kim HW; Li H; Seo MS; Jung WK; Ha KS; Han ET; Hong SH; Firth AL; Choi IW; Park WS Clin Exp Pharmacol Physiol; 2018 Dec; 45(12):1286-1292. PubMed ID: 30028903 [TBL] [Abstract][Full Text] [Related]
17. Vernakalant activates human cardiac K(2P)17.1 background K(+) channels. Seyler C; Schweizer PA; Zitron E; Katus HA; Thomas D Biochem Biophys Res Commun; 2014 Aug; 451(3):415-20. PubMed ID: 25108155 [TBL] [Abstract][Full Text] [Related]
18. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. Slawsky MT; Castle NA J Pharmacol Exp Ther; 1994 Apr; 269(1):66-74. PubMed ID: 8169853 [TBL] [Abstract][Full Text] [Related]
19. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide. Wang GK; Russell C; Wang SY J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091 [TBL] [Abstract][Full Text] [Related]
20. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]